microRNA 1264 (miR-1264)

microRNA 1264 (miR-1264) is classified as a human microRNA, a small non-coding RNA molecule that functions in post-transcriptional regulation of gene expression by binding to complementary sequences in target messenger RNAs (mRNAs), resulting in gene silencing via translational repression or target degradation[3][1]. MicroRNAs, denoted by prefixes like "hsa-" for human, are broadly involved in numerous cellular processes, including development, differentiation, proliferation, and apoptosis, and frequently show dysregulation in diseases such as cancer[3][1][4]. miR-1264 follows standard biogenesis and nomenclature typical of other microRNAs (being processed from a specific precursor RNA, with species-specific identifiers and possible isomiR variants), but there is very limited or no specific information in the scientific literature to indicate that MIR1264 acts as a therapeutic target, biomarker, or has a well-defined role in human disease or pharmacology. This strongly suggests that MIR1264 is not a canonical drug target (such as receptors, enzymes, or transporters), and its direct therapeutic relevance is currently not established[1][3]. Note: There is no current robust evidence supporting MIR1264 as a standalone therapeutic target, biomarker, or direct drug-interaction partner. If you are seeking molecular targets for drug discovery or translational research, a different gene or protein would be more appropriate. The name and aliases provided align with standard miRNA nomenclature, but authoritative databases and current literature do not list miR-1264 as a clinically relevant target, hence "is_incorrect" is set to true for this use case.

Other names

MIR1264hsa-mir-1264MIRN1264